AI assistant
Sending…
SYNAPTICS Inc — Director's Dealing 2020
Jul 23, 2020
31479_dirs_2020-07-23_74c6c175-2b29-4092-980a-b78f24a4e07c.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: SYNAPTICS Inc (SYNA)
CIK: 0000817720
Period of Report: 2020-07-21
Reporting Person: NOLAN KERMIT (See Remarks)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2020-07-21 | Common Stock | M | 744 | $60.22 | Acquired | 55737 | Direct |
| 2020-07-21 | Common Stock | M | 744 | $61.40 | Acquired | 56481 | Direct |
| 2020-07-21 | Common Stock | S | 4000 | $80.00 | Disposed | 52481 | Direct |
| 2020-07-21 | Common Stock | S | 1488 | $78.22 | Disposed | 50993 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2020-07-21 | Employee Stock Option (Right to Buy) | $60.22 | M | 744 | Disposed | 2021-01-27 | Common Stock (744) | Direct |
| 2020-07-21 | Employee Stock Option (Right to Buy) | $61.40 | M | 744 | Disposed | 2021-04-28 | Common Stock (744) | Direct |
Footnotes
F1: The shares were sold pursuant to a 10b5-1 Trading Plan dated February 18, 2020.
F2: 1/12th of the total number of shares subject to the option vested and became exercisable each quarter following the January 27, 2014 date of grant until fully vested on January 27, 2017.
F3: 1/12th of the total number of shares subject to the option vested and became exercisable each quarter following the April 28, 2014 date of grant until fully vested on April 28, 2017.
More from SYNAPTICS Inc
Regulatory Filings
2026
May 27
Interim / Quarterly Report
2026
May 7
Earnings Release
2026
May 7
Major Shareholding Notification
2026
Apr 30
Major Shareholding Notification
2026
Apr 29
Major Shareholding Notification
2026
Mar 27
Director's Dealing
2026
Mar 18
Regulatory Filings
2026
Mar 18
Director's Dealing
2026
Mar 18
Director's Dealing
2026
Mar 18